Healthcare Magazine January 2015 | Page 24

Cyramza by Eli Lilly and Company
top 10

Big pharma is driving progress in the major causes of death around the world . The following drugs created by their respective companies reflect the most promising medical breakthroughs that will impact patients in the coming year .

10

Cyramza by Eli Lilly and Company

Eli Lilly and Company ’ s ( NYSE : LLY ) drug Cyramza was recently approved by the FDA as a treatment for people with advanced or metastatic gastric ( stomach ) cancer . The approval of this combination regimen is for patients whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy . Stomach cancer is the fifth most common cancer in the world and is the third-leading cause of cancer death .
www . lilly . com
24 January 2015